Phibro Animal Health Corporation (PAHC) Actualités

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance

Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Phibro Animal Health Corporation Declares Quarterly Dividend

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its...

Form 8-K - Current report

Phibro Animal Health Corporation Completes Acquisition of Zoetis’ Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products

Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the successful completion of the acquisition of the medicated feed additive...

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 6, 2024, after the...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Morgan Stanley Annual Global Healthcare Conference...